Preliminary phase 3 trial data indicate padeliporfin vascular targeted photodynamic therapy has favorable efficacy and acceptable safety for low-grade UTUC. The use of padeliporfin vascular targeted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results